Search results
Showing 7876 to 7890 of 8899 results
Interventional procedures, IPG354 - Issued: July 2010 --> We have moved interventional procedures guidance 354 to become HealthTech guidance 227. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Macular translocation with 360° retinotomy for wet age-related macular degeneration (IPG340)
We have moved interventional procedures guidance 340 to become HealthTech guidance 216. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Extracranial to intracranial bypass for intracranial atherosclerosis (IPG348)
This guidance has been updated and replaced by NICE interventional procedures guidance 596.
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia (IPG355)
Interventional procedures, IPG355 - Issued: September 2010 --> We have moved interventional procedures guidance 355 to become HealthTech guidance 228. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guidance has been updated and replaced by NICE HealthTech guidance 603.
Interventional procedures, IPG463 - Issued: August 2013 --> This guidance has been updated and replaced by NICE HealthTech guidance 603.
Gantenerumab for treating early Alzheimer's disease [ID6142]
In development Reference number: GID-TA11269 Expected publication date: TBC
In development Reference number: GID-TA11251 Expected publication date: TBC
Giroctocogene fitelparvovec for treating moderately severe to severe haemophilia A [ID6312]
In development Reference number: GID-TA11329 Expected publication date: TBC
In development Reference number: GID-TA11805 Expected publication date: TBC
October 2018: This process guide has been updated. The updated version can be found in the tools and resources for developing NICE guidelines: the manual.
Process manual for the endorsement of guidance and quality standard support resources (PMG29)
The endorsement programme is now closed and no new applications are being accepted. Information about existing endorsed resources, are available on the endorsement webpage. Please email endorsement@nice.org.uk if you have any queries.
Medicines optimisation: key therapeutic topics – Integrated process statement (PMG13)
February 2022: we have withdrawn our medicines optimisation: key therapeutic topics. We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy. If you have any queries, please contact nice@nice.org.uk.
Process guide for adoption support resources for health technologies (PMG23)
This process and methods guide has been withdrawn.
Medical technologies evaluation programme methods guide (PMG33)
This medical technologies evaluation programme methods guide has been replaced by the NICE HealthTech programme manual.